Home  >  News
News
  Endo Pharma recalls one lot of Edex 10 mcg 2 pack carton due to potential lack of sterility assurance,   February 27, 2017
  Zydus’ subsidiary Nesher Pharma gets US FDA nod to market oseltamivir phosphate capsules,   February 27, 2017
  Ortho seeks US FDA marketing approval for VITROS HIV combo assay for use on Vitros 3600 immunodiagnostic system,   February 27, 2017
  Zydus Cadila receives approvals from DCGI, CDSCO and CDL to market tetravalent inactivated influenza vaccine VaxiFlu-4,   February 24, 2017
  Adapt Pharma seeks European marketing approval for naloxone HCl nasal spray to treat opioid overdose,   February 23, 2017
  Sobi inks pact with Valeant Pharma to distribute Ammonul in Europe, ME & North Africa,   February 22, 2017
  Chugai’s anti-cancer agent Alecensa receives European conditional marketing authorization,   February 22, 2017
  TerSera Therapeutics to commercialise AstraZeneca's Zoladex in US & Canada,   February 21, 2017
  Hologic's Aptima HCV Quant Dx assay receives US FDA pre-market approval,   February 17, 2017
  Eli Lilly and Company, Incyte Corporation receives marketing authorisation for Olumiant from European Commission,   February 14, 2017
  Hikma Pharmaceuticals to market Orion’s dry powder inhaler 'Easyhaler' in MENA markets,   February 14, 2017
  Ariad Pharma seeks European marketing approval for Brigatinib,   February 08, 2017
  J&H Co receives South Korean approval to market Zestra,   February 07, 2017
  Dipharma, Alvogen introduce Diterin in South Korea to treat HPA due to PKU,   February 07, 2017
  Optibrium inks pact with Zastra Innovations for distribution in India,   February 06, 2017
  Lupin gets US FDA marketing nod for triamcinolone acetonide cream,   February 03, 2017
  Crescita launches ISDIN Acnisdin & Nutratopic product lines at Brunet pharmacy chains,   January 28, 2017
  Novartis' eye care division Alcon introduces AcrySof IQ PanOptix Toric intraocular lens for patients with astigmatism undergoing cataract surgery,   January 28, 2017
  EMA accepts Novelion Therapeutics’ MAA for metreleptin,   January 25, 2017
  EMA validates MAA for AbbVie's investigational regimen of glecaprevir/pibrentasvir to treat chronic hepatitis C in all major genotypes,   January 25, 2017

 Back
 
chemspec2017
CPHI-Istanbul-2017-150x60-stat-V1
cphikorea_150x60_k
CPhI-SEA-2017-150x50-stat-v1
pharmalogisticssummit-150-60
cphi_japanBanner150x60_2017
Pharma Project Management 2017
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |